Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Neoplasms, Plasma Cell 1 Multiple Myeloma 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell 1 Locally Advanced Breast Cancer 1 Hepatitis 1 Fibrosis 1 Endometrial Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

Dexamethasone 64 Cyclophosphamide 40 Bortezomib 37 Melphalan 24 Lenalidomide 23 Thalidomide 17 pomalidomide 16 fludarabine 12 daratumumab 11 carfilzomib 10 Filgrastim 8 Doxorubicin 8 Busulfan 6 Prednisone 5 Peripheral Blood Stem Cell Transplantation 5 Bendamustine Hydrochloride 5 selinexor 4 sargramostim 4 isatuximab 4 fludarabine phosphate 4 Surveys and Questionnaires 4 Etoposide 4 Clarithromycin 4 Calcium Dobesilate 4 liposomal doxorubicin 3 ixazomib 3 Radiotherapy 3 Neoadjuvant Therapy 3 Mycophenolic Acid 3 Methylprednisolone 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Multiple Myeloma × Clinical Protocols × Clear all

NCT01554852 2018-06-11

Myeloma XI

University of Leeds

Phase 3 Unknown

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡